ifosfamide has been researched along with Ependymoma in 7 studies
Ependymoma: Glioma derived from EPENDYMOGLIAL CELLS that tend to present as malignant intracranial tumors in children and as benign intraspinal neoplasms in adults. It may arise from any level of the ventricular system or central canal of the spinal cord. Intracranial ependymomas most frequently originate in the FOURTH VENTRICLE and histologically are densely cellular tumors which may contain ependymal tubules and perivascular pseudorosettes. Spinal ependymomas are usually benign papillary or myxopapillary tumors. (From DeVita et al., Principles and Practice of Oncology, 5th ed, p2018; Escourolle et al., Manual of Basic Neuropathology, 2nd ed, pp28-9)
| Excerpt | Relevance | Reference |
|---|---|---|
| " To assess the impact of adjuvant chemotherapy, we reviewed the overall survival of consecutive patients with anaplastic ependymoma treated over a 10-year period with surgery and ICE (ifosfamide+ VP 16+carboplatin) chemotherapy with or without radiation at our institution." | 3.70 | Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymomas. ( Baruchel, S; Chan, H; Fouladi, M; Grant, R; Greenberg, ML; Malkin, D; Weitzman, S, 1998) |
| "The role of chemotherapy in the treatment of ependymoma has not been established." | 2.68 | Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. ( Bergman, I; Cnaan, A; Garvin, JH; Goldwein, JW; Grass, J; Molloy, P; Needle, MN; Phillips, PC; Sutton, L; Zhao, H, 1997) |
| "The adverse effects of combination chemotherapy of ifosfamide, cisplatin, and etoposide (ICE) were evaluated in the treatment of various intracranial brain tumors." | 1.36 | [The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases]. ( Kanamori, M; Kumabe, T; Saito, R; Sonoda, Y; Tominaga, T; Yamashita, Y, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gramatzki, D | 1 |
| Roth, P | 1 |
| Felsberg, J | 1 |
| Hofer, S | 1 |
| Rushing, EJ | 1 |
| Hentschel, B | 1 |
| Westphal, M | 1 |
| Krex, D | 1 |
| Simon, M | 1 |
| Schnell, O | 1 |
| Wick, W | 1 |
| Reifenberger, G | 1 |
| Weller, M | 1 |
| Hino, M | 1 |
| Kobayashi, Y | 1 |
| Wada, M | 1 |
| Hattori, Y | 1 |
| Kurahasi, T | 1 |
| Nakagawa, H | 1 |
| Kanamori, M | 1 |
| Kumabe, T | 1 |
| Saito, R | 1 |
| Yamashita, Y | 1 |
| Sonoda, Y | 1 |
| Tominaga, T | 1 |
| Geyer, JR | 1 |
| Sposto, R | 1 |
| Jennings, M | 1 |
| Boyett, JM | 1 |
| Axtell, RA | 1 |
| Breiger, D | 1 |
| Broxson, E | 1 |
| Donahue, B | 1 |
| Finlay, JL | 1 |
| Goldwein, JW | 2 |
| Heier, LA | 1 |
| Johnson, D | 1 |
| Mazewski, C | 1 |
| Miller, DC | 1 |
| Packer, R | 1 |
| Puccetti, D | 1 |
| Radcliffe, J | 1 |
| Tao, ML | 1 |
| Shiminski-Maher, T | 1 |
| Heideman, RL | 1 |
| Douglass, EC | 1 |
| Langston, JA | 1 |
| Krischer, JP | 1 |
| Burger, PC | 1 |
| Kovnar, EH | 1 |
| Kun, LE | 1 |
| Friedman, HS | 1 |
| Kadota, R | 1 |
| Needle, MN | 1 |
| Grass, J | 1 |
| Cnaan, A | 1 |
| Bergman, I | 1 |
| Molloy, P | 1 |
| Sutton, L | 1 |
| Zhao, H | 1 |
| Garvin, JH | 1 |
| Phillips, PC | 1 |
| Fouladi, M | 1 |
| Baruchel, S | 1 |
| Chan, H | 1 |
| Grant, R | 1 |
| Malkin, D | 1 |
| Weitzman, S | 1 |
| Greenberg, ML | 1 |
3 trials available for ifosfamide and Ependymoma
| Article | Year |
|---|---|
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Preschool; Cisplatin; Combin | 2005 |
A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Astrocytoma; Brain Neoplasms; Carcinoma; Child | 1995 |
Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Chemothera | 1997 |
4 other studies available for ifosfamide and Ependymoma
| Article | Year |
|---|---|
Chemotherapy for intracranial ependymoma in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Dis | 2016 |
Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; | 2016 |
[The safety of combination chemotherapy with ifosfamide, cisplatin, and etoposide (ICE): single-institution retrospective review of 108 cases].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, | 2010 |
Use of adjuvant ICE chemotherapy in the treatment of anaplastic ependymomas.
Topics: Aging; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cerebellar Neoplasms; Child; Chi | 1998 |